< Back to all Breaking News
RFL
12/11/2018 08:12am
Rafael Pharmaceuticals initiates Phase 3 AVENGER 500 trial
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.